Uninterrupted dabigatran approved for use during AF ablation

The TGA has signed off on a change to prescribing information for dabigatran (Pradaxa) confirming it as the only NOAC that can be continued in patients with atrial fibrillation undergoing a catheter ablation for rhythm control. The change is consistent with the recently published NHFA/CSANZ Australia Clinical Guidelines for the Diagnosis and Management of Atrial ...

Already a member?

Login to keep reading.

© 2021 the limbic